Clinical Trial Update: First Time in Human Study [Phase 1]

View source ↗

Summary

First-in-human Phase 1 trial for depressive and anxiety disorders sponsored by GlaxoSmithKline has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Major Depressive Disorder

Snippet

Sponsor: GlaxoSmithKline | Conditions: Depressive Disorder and Anxiety Disorders | Phase 1 | Status: COMPLETED